ACR acrux limited
Add to My Watchlist 16.7% ! 2.1¢

I’m curious why the drug development isn’t classified as...

  1. BigPoppaBear
    388 Posts.
    lightbulb Created with Sketch. 85
    clock Created with Sketch.
    02/03/20
    23:32
    Post #: 43268711
    I’m curious why the drug development isn’t classified as intangibles. Surely development costs should be capitalised.. am I missing something here with generics portfolio. If that’s the case.. the balance sheet is significantly under capitalised
    ACR Price at posting: 13.5¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS World’s largest pollucite-hosted caesium pegmatite resource defined
right-arrow Created with Sketch.
NEWS AnteoTech and Black Diamond Structures to Progress Advanced Battery Product in the USA
right-arrow Created with Sketch.
NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.1¢ 		Change
0.003(16.7%) 		Mkt cap ! $8.594M
Open High Low Value Volume
1.8¢ 2.1¢ 1.8¢ $5.89K 300.8K

Buyers (Bids)

No. Vol. Price($)
4 246823 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 203465 1
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.